Kalvista Pharmaceuticals Inc (KALV.OQ)
KALV.OQ on NASDAQ Stock Exchange Global Market
18.33USD
22 Jul 2019
18.33USD
22 Jul 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$18.33
$18.33
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
53,122
53,122
52-wk High
$34.65
$34.65
52-wk Low
$8.01
$8.01
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Buy | -0.45 | April | 23 Jul 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 3 | 3 | 3 | 3 |
| (2) OUTPERFORM | 3 | 3 | 3 | 3 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.50 | 1.50 | 1.50 | 1.50 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jan-19 | 5 | 4.25 | 5.40 | 3.00 | -- |
| Quarter Ending Apr-19 | 6 | 4.04 | 5.03 | 3.00 | -- |
| Year Ending Apr-19 | 6 | 16.82 | 17.40 | 15.30 | -- |
| Year Ending Apr-20 | 6 | 33.46 | 73.00 | 10.00 | 19.40 |
| Year Ending Apr-21 | 5 | 34.06 | 140.10 | 2.00 | 10.00 |
| Earnings (per share) | |||||
| Quarter Ending Jan-19 | 5 | -0.45 | -0.23 | -0.62 | -- |
| Quarter Ending Apr-19 | 6 | -0.42 | -0.28 | -0.79 | -- |
| Year Ending Apr-19 | 6 | -1.37 | -1.16 | -2.11 | -- |
| Year Ending Apr-20 | 5 | -1.52 | 0.93 | -3.71 | -0.54 |
| Year Ending Apr-21 | 5 | -2.01 | 3.70 | -3.83 | -- |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Apr-19 | 4.04 | 2.93 | 1.11 | 27.55 |
| Quarter Ending Jan-19 | 4.25 | 3.89 | 0.36 | 8.39 |
| Quarter Ending Oct-18 | 3.74 | 5.59 | 1.85 | 49.57 |
| Quarter Ending Jul-18 | 3.81 | 3.72 | 0.09 | 2.30 |
| Quarter Ending Apr-18 | 3.65 | 4.84 | 1.19 | 32.60 |
| Earnings (per share) | ||||
| Quarter Ending Apr-19 | -0.42 | -0.49 | 0.07 | -16.20 |
| Quarter Ending Jan-19 | -0.45 | -0.23 | 0.22 | -48.66 |
| Quarter Ending Oct-18 | -0.46 | -0.22 | 0.24 | -52.38 |
| Quarter Ending Jul-18 | -0.33 | -0.47 | 0.14 | -42.42 |
| Quarter Ending Apr-18 | -0.35 | -0.06 | 0.29 | -82.57 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jan-19 | 4.25 | -- | -- | -- | -- |
| Quarter Ending Apr-19 | 4.04 | -- | -- | -- | -- |
| Year Ending Apr-19 | 16.82 | -- | -- | -- | -- |
| Year Ending Apr-20 | 33.46 | 29.20 | 30.40 | 30.40 | 19.40 |
| Year Ending Apr-21 | 34.06 | 8.00 | 6.04 | 6.04 | 10.00 |
| Earnings (per share) | |||||
| Quarter Ending Jan-19 | -0.45 | -- | -- | -- | -- |
| Quarter Ending Apr-19 | -0.42 | -- | -- | -- | -- |
| Year Ending Apr-19 | -1.37 | -- | -- | -- | -- |
| Year Ending Apr-20 | -1.52 | -1.47 | -1.47 | -1.47 | -0.54 |
| Year Ending Apr-21 | -2.01 | -3.50 | -3.50 | -3.50 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jan-19 | -- | -- | -- | -- |
| Quarter Ending Apr-19 | -- | -- | -- | -- |
| Year Ending Apr-19 | -- | -- | -- | -- |
| Year Ending Apr-20 | 2 | 1 | 2 | 1 |
| Year Ending Apr-21 | 0 | 1 | 0 | 1 |
| Earnings | ||||
| Quarter Ending Jan-19 | -- | -- | -- | -- |
| Quarter Ending Apr-19 | -- | -- | -- | -- |
| Year Ending Apr-19 | -- | -- | -- | -- |
| Year Ending Apr-20 | 3 | 2 | 3 | 2 |
| Year Ending Apr-21 | 1 | 2 | 1 | 2 |
Earnings vs. 
Estimates